Autopsy report · NCT02631148
Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.
Cause of deathDrug or device supply
“International shortage of the chemical para-aminohippuric acid (PAH) due to manufacturing changes, led to inability to perform key measurements to meet trial objectives”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years before it stopped.
- 12 participants enrolled.
- Results were posted on the registry 3 years 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Obesity; Prediabetic State
- Interventions
- Melatonin; Placebo
- Participants
- 12
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.